Detect Neisseria gonorrhoeae and ciprofloxacin susceptibility markers
Dual N. gonorrhoeae targets (opa & porA), gyrA S91F mutant, & gyrA S91 wildtype in a single-well multiplex qPCR test
Antibiotic resistance in gonorrhoea infections is a global concern. There are limited effective treatment options and novel antibiotics are not readily available. Smarter and more directed use of antibiotics can be achieved through Resistance Guided Therapy.
Tested on hundreds of clinical samples, ResistancePlus® GC demonstrates excellent sensitivity and specificity.
Streamline your workflow and increase productivity for rapid, routine diagnostics. Full automation options including sample and qPCR set-up, through to validated software solutions for automated result calling and simple data processing.
SpeeDx analysis software included in contract pricing is license free and installed on a high security and GDPR compliant platform:
Increase capacity of your existing qPCR instrumentation through universal run conditions compatible with all ResistancePlus® products.
Demonstrated clinical performance – for more detail please see the ResistancePlus® GC Instructions for Use.
|Performance of ResistancePlus® GC|
|GC detection||gyrA S91F Detection|
ResistancePlus® GC simultaneously detects the bacterium Neisseria gonorrhoeae (GC) and the gyrA S91 (wild type) or gyrA S91F (mutant) markers that are associated with susceptibility or resistance to the fluoroquinolone antibiotic, ciprofloxacin.
Single well: N. gonorrhoeae (Opa), N. gonorrhoeae (PorA), Ciprofloxacin resistance, Ciprofloxacin susceptibility, Internal control
Products are shipped on dry ice or ice gel packs.
Expiry dates are stated on the labels. It is recommended that freeze/thaw cycles be limited to less than 15. Store protected from light at – 20°C.
For in vitro diagnostic use. Not for sale in the USA.
CE-IVD, TGA cleared
Please contact your local representative if you can’t find what you are looking for.
We are committed to supporting continued scientific discovery and generation of clinically relevant data. Collaborations with key researchers and clinicians around the globe help us improve diagnostics and address urgent clinical needs.
Evaluation of the ResistancePlus GC (Beta) Assay: A Commercial Diagnostic Test for the Direct Detection of Ciprofloxacin Susceptibility or Resistance in Neisseria Gonorrhoeae
Evaluating the performance of the ResistancePlus® GC (beta) assay for the simultaneous detection of Neisseria gonorrhoeae and gyrA S91 markers of resistance (S91F) and susceptibility (WT) to ciprofloxacin, from both clinical specimens and isolates.
Improved Determination of Neisseria Gonorrhoeae Gyrase A Genotype Results in Clinical Specimens
The ResistancePlus® GC (beta) assay showed improved N. gonorrhoeae gyrA genotype determination compared with a prior gyrA genotypic high-resolution melt assay.
Towards Individualised Treatment of Gonorrhoea
Discussion on the evolution of resistance in gonorrhoea, and to the design and application of diagnostic molecular tests for antibiotic resistance in gonorrhoea. Speaks to the mutations linked to ciprofloxacin susceptibility and resistance and introduces the broad-reaching clinical trials ongoing in Australia.
Please contact SpeeDx for information about offering SpeeDx diagnostics in your clinic or for a list of current pathology clinics where SpeeDx testing is available.
|ResistancePlus® GC*||LC480 II†||100 reactions||2011001|
|ABI 7500 / ABI 7500 Fast /
ABI 7500 Fast Dx҂
|CFX96 IVD/CFX96 Touch#||100 reactions||2015001|
|ResistancePlus® GC Analysis Software*||LC480 II||1 unit||99010|
|ABI 7500 / ABI 7500 Fast /
ABI 7500 Fast Dx
|CFX96 IVD/CFX96 Touch||1 unit||99015|
|PlexPCR® Colour Compensation*^ kit||LC480 II||2 reactions||90001|
|ResistancePlus® GC Control* kit||All platforms||10 reactions||95003|
*Not for sale in USA
†Validated on LightCycler 480 II
҂Validated on ABI 7500 Fast and ABI 7500 Fast Dx
#Validated on CFX96 IVD and CFX96 Touch
^Supplied upon request. This kit is only required for initial set-up to establish calibration of PlexPCR® and ResistancePlus® kits on the LC480 instrument, see instruction for use for details.